Free Whitepaper

From GCP to GVP:

A Pharmacovigilance Guide for Emerging Biotech Firms

Recommended for Executives and Professionals in PV, RA and Quality

Identification of core areas that are of strategic importance and require special oversight.

Recognize strategic considerations and assess risks and opportunities.

A seven-step guide how to develop the right capabilities.

Whitepaper Preview


    *Mandatory fields.

    About the Author

    Stefan Brüning
    Dipl.-Biol., MBA, PMP®, IMCM®, MRQA

    References
    Daniel Regut

    "I have worked together with Stefan over several years and have gotten to know him as a highly motivated professional, with whom it's a pleasure to work with. Not only a cooperative and pleasant spirit, but a person with a highly analytical, sharp mind who gets to the root of problems, finds solutions and has the ability to take the team with him while striving for and implementing solutions."

    Daniel Regut
    Sr. Clinical Research Associate & CRA Trainer